JNCI Journal of the National Cancer Institute · 1965 · 35 citations · 0 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisCircadian RhythmsBreast Cancer PharmacotherapyCell Cycle PharmacologyCircadian Clock MechanismsCircadian EndocrinologyCircadian PharmacologyCircadian Physiology24-Hour TimeCircadian Rhythm PhysiologyDrug ChronodynamicsMalignant Breast TumorsMammalian Circadian TimingMitotic Activity AssessmentMitotic FiguresRodent Circadian Rhythms
The persistence of a circadian rhythm is reported in the mitotic activity of a mammary carcinoma of a C3H/Mza female mouse after 35 transplant generations carried out over a 3-year period. The possible causes of the different results found in the literature on mitotic rhythms in malignant tumors are analyzed. The antitumor effect of Endoxan administered at different times during a 24-hour period is also reported. This drug is more effective if administered when the mitotic activity of the tumor is high (4 am, 8 am, noon, and 4 pm) than when the mitotic activity is low (8 pm and midnight). The practical importance of this fact is emphasized.